CLINICAL_TRIALS
trial_result
· 2016-09-02
Clinical Trial Update: RDEA3170 PK/PD Study [Phase 1]
Summary
Phase 1 PK/PD study of RDEA3170 for gout has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 1 | Status: COMPLETED